At the conclusion of this activity, participants will be able to:


1.  Identify distinctive features of juvenile dermatomyositis

2.  Describe emerging treatment approaches for juvenile dermatomyositis

3.  Highlight emerging outcomes of concern in juvenile dermatomyositis

Session date: 
04/04/2023 - 8:30am to 9:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kaveh Ardalan, M.D., M.S